Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Lymphoid 3Genitourinary 3Thoracic 2Sarcoma 2Plasma cell 2Other hematologic neoplasm 2CNS 2Tumor-Agnostic 1Myeloid 1Gastrointestinal 1Classical hematology 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Recurrence 1Gliosarcoma 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × palbociclib × Sarcoma × Clear all
NCT04129151 2024-08-01

Palbociclib + Ganitumab In Ewing Sarcoma

Dana-Farber Cancer Institute

Phase 2 Terminated
10 enrolled 15 charts
Sarcoma

Recurrence, Sarcoma, Sarcoma, Ewing

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated
23 enrolled 8 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡